Clinical trial
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
NCT00199732 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
- Lead sponsor
- University Hospital, Limoges
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- July 31, 2009
- Enrollment
- 19 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis b